CVE-2015-3956
Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.95%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
- CVSS 3.0
- 9.8 CRITICALCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.95% probability · 59th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-345
- Affected
- pifzer/plum a\+ infusion system firmware · pifzer/plum a\+3 infusion system firmware · pifzer/symbiq infusion system firmware
- Source
- ics-cert@hq.dhs.gov
References
- https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01Mitigation, Third Party Advisory, US Government Resource
- https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01Mitigation, Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.